Informa Australia is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

Find Topic

Healthcare

Smartphones and tablets will aid consumerisation of healthcare in 2011

Melbourne, 6th December 2010. Consumer-driven healthcare will gather momentum in 2011 as the public takes more responsibility for its own health, with technology playing a key role, according to Ovum. In a new report* the independent technology analyst states that devices such as smartphones and tablet computers will help to drive the consumerisation of healthcare…

6 Dec 2010, by Informa Insights

Business | Social Policy

An unashamedly relevant examination of social media’s capacity for revenue generation

We hear about it. We talk about it. We use it everyday. Businesses adopting social media is easy, but doing it right is not. Here's a chance for us to learn how to get it right. [youtube=http://www.youtube.com/watch?v=ZrIDRaTpja4] The Corporate Social Media Summit 2011 is happening on the 30th-31st March 2011 at the Sydney Harbour Marriott…

1 Dec 2010, by Informa Insights

Healthcare

Disappointing year for Roche but restructuring will help maintain strong fiscal position

Melbourne, 18th November 2010 - John Bird, pharmaceutical company analyst at Datamontior, comments on Roche’s plans to cut 6 percent of its global workforce, or 4800 jobs, over the next two years as part of efforts to make annual cost savings of $2.4 billion: “Many Big Pharma companies have restructured in recent times due to…

18 Nov 2010, by Informa Insights

Healthcare

Market development key for testosterone replacement therapy

Melbourne, 17th November 2010 - Despite growing at a compound annual growth rate of more than 24% over the last five years, the testosterone replacement therapy market is severely underdeveloped. This suggests there are great opportunities for pharmaceutical companies in this field, claims independent market analyst, Datamonitor*. The testosterone replacement therapy market, valued at $838m…

17 Nov 2010, by Informa Insights

Healthcare

Can Pfizer rescue hormonal replacement therapy?

Melbourne, 17th November 2010 - In a market still plagued with safety concerns, Pfizer has an opportunity to restore market growth for hormonal replacement therapy (HRT) with its new combination product, Aprela. To do this it must rebuild public and general practitioner confidence in the therapy area, says independent market analyst, Datamonitor*. The value of…

17 Nov 2010, by Informa Insights

Education

A question of culture as well as structure

IGNORING the entrenched prejudices of further and higher education can lead to divorce. IN 2004, Thames Valley University, a former English polytechnic based in west London, merged with Reading College, a further education institution (or TAFE). The merger was historic, creating England's first dual-sector university. The talk was about providing seamless transition from further to…

1 Nov 2010, by Informa Insights

Healthcare

Pfizer to acquire King Pharmaceuticals for $3.6 billion.

Expert comment from Datamonitor principal analyst Simon King: “The King acquisition represents a small but integral part of a broader diversification strategy that continues to be implemented by Pfizer. This strategy has to date encompassed the multi-billion dollar acquisition of Wyeth but also various in-licensing agreements and a concerted movement into the generics market as…

15 Oct 2010, by Informa Insights

Healthcare

The case for constant innovation in Australian biotech

Melbourne – 12th October 2010 – The sales contribution from internally developed products is expected to decline from $284 billion in 2009 to $274 billion in 2014, by which time the majority of sales will be derived from externally sourced products. Pharma’s continued need to restock pipelines in order to secure future growth—in the face…

12 Oct 2010, by Informa Insights

Planning & Design | Transport & Logistics

Written interview with the CEO of NSW Business Chamber

We had the opportunity to get an interview with Stephen Cartwright, CEO, NSW Business Chamber, who is nice enough to give us a few minutes of his busy day to fill in some blanks for us! Building and maintaining transport infrastructure is of pivotal importance for the future prosperity of NSW. We had the chance…

11 Oct 2010, by Informa Insights

Healthcare

Asia-Pacific products are in later stages of development compared to other markets

Melbourne – 11th October 2010 – Asia-Pacific products are in later stages of development compared to other markets, but still comprise only 15% of global products in development according to MedTRACK, a market leading database of private and public biomedical companies. The volume of products in development in the Asia-Pacific region still lags behind North…

11 Oct 2010, by Informa Insights
Page  of 151

Get all the latest on Informa news and events

Informa Connect Australia is the nation's leading event organiser. Our events comprise of large scale exhibitions, industry conferences and highly specialised corporate training.

Find out more

Subscribe to Insights
SUBSCRIBE 

Join Our Newsletter
Informa Insights

Stay up-to-date with all the latest
updates, upcoming events & more.
close-link
COVID-19 Informa Connect Update + Policy
Learn More
close-image